Establishment of reference intervals for kaolin-activated thromboelastography in dogs including an assessment of the effects of sex and anticoagulant use

Journal of Veterinary Diagnostic Investigation

Volumn 21, Issue 5, 2009, Pages 641-648

  Bauer, Natali ^a   Eralp, Oya ^a   Moritz, Andreas ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Anticoagulant; Canine; Fibrinolysis; Hemostasis; Reference interval; Thromboelastogram

Indexed keywords

CANIS FAMILIARIS;

EID: 70349671618     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870902100508     Document Type: Article

References (30)

1. Adcock D, Kressin D, Marlar RA: 1998, The effect of time and temperature variables on routine coagulation tests. Blood Coagul Fibrinolysis 9:463-470.
2. Bauer N, Moritz A: 2008, Koagulopathien bei Hund und Katze [Coagulopathies in dogs and cats]. Tierarztl Prax 36:235-246. In German. Abstract in English.
3. Bowbrick VA, Mikhailidis DP, Stansby G: 2000, The use of citrated whole blood in thromboelastography. Anesth Analg 90:1086-1088.
4. Camenzind V, Bombeli T, Seifert B, et al.: 2000, Citrate storage affects ThrombelastographH analysis. Anesthesiology 92:1242-1249.
5. Chan KL, Summerhayes RG, Ignjatovic V, et al.: 2007, Reference values for kaolin-activated thromboelastography in healthy children. Anesth Analg 105:1610-1613.
6. Chandler WL: 1995, The thromboelastography and the thromboelastograph technique. Semin Thromb Hemost 21(Suppl. 4):1-6.
7. Dimauro C, Bonelli P, Nicolussi P, et al.: 2008, Estimating clinical chemistry reference values based on an existing data set of unselected animals. Vet J 178:278-281.
8. Dodds WJ: 1997, Hemostasis. In: Clinical biochemistry of domestic animals, ed. Kaneko JJ, Harvey JW, Bruss ML, pp. 241-283. Academic Press, London, UK.
9. Dolan G, Neal K, Cooper P, et al.: 1994, Protein C, antithrombin III and plasminogen: effect of age, sex and blood group. Br J Haematol 86:798-803.
10. Donahue S, Otto CM: 2005, Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J Vet Emerg Crit Care 15:9-15.
11. Edwards RM, Naik-Mathuria BJ, Gay AN, et al.: 2008, Parameters of thromboelastography in healthy newborns. Am J Clin Pathol 130:99-102.
12. Farver TB: 2008, Concepts of normality in clinical biochemistry. In: Clinical biochemistry of domestic animals, ed. Kaneko JJ, Harvey JW, Busse L, 6th ed., pp. 1-25. Academic Press, London, UK.
13. Haemoscope Corporation: 2001, TEGH design and principles of operation. In: TEGH 5000 user's manual, 1st ed., pp. 1-15. Haemoscope Corp, Niles, IL.
14. Horn PS, Pesce AJ: 2003, Reference intervals: an update. Clin Chim Acta 334:5-23.
15. Hughes R, Thomson K, Hopkins R, et al.: 2005, Determinants of plasma D-dimer levels in a traveling population. J Thromb Haemost 3:2445-2448.
16. Kristensen AT, Wiinberg B, Jessen LR, et al.: 2008, Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 22:140-147.
17. Mallett SV, Cox DJ: 1992, Thrombelastography. Br J Anaesth 69:307-313.
18. Mischke R: 2005, Hamostase [Hemostasis]. In: Klinische Labordiagnostik in der Tiermedizin, ed. Kraft W, Durr UM, 6th ed., pp. 115-144. Schattauer, Stuttgart, Germany. Article in German.
19. Papp AC, Hatzakis H, Bracey A, Wu KK: 1989, ARIC hemostasis study: I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 61:15-19.
20. Pivalizza EG, Pivalizza PJ, Gottschalk LI, et al.: 2001, Celite-activated thrombelastography in children. J Clin Anesth 13:20-23.
21. Rajwal S, Richards M, O'Meara M: 2004, The use of recalcified citrated whole blood-a pragmatic approach for thromboelas- tography in children. Paediatr Anaesth 14:656-660.
22. Sakata T, Okamoto A, Morita T, et al.: 2007, Age- and gender-related differences of plasma prothrombin activity levels. Thromb Haemost 97:1052-1053.
23. Solberg HE: 1987, Approved recommendation on the theory of reference values: Part 5. Statistical treatment of reference values. Determination of reference limits. J Clin Chem Clin Biochem 25:645-656.
24. Tanaka KA, Szlam F, Katori N, et al.: 2004, Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro. Thromb Res 113:333-339.
25. Vilar P, Couto CG, Westendorf N, et al.: 2008, Thrombo-elastographic tracings in retired racing greyhounds and in non-greyhound dogs. J Vet Intern Med 22:374-379.
26. Wiinberg B, Jensen AL, Johansson PI, et al.: 2008, Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 22:357-365.
27. Wiinberg B, Jensen AL, Kjelgaard-Hansen M, et al.: 2007, Study on biological variation of haemostatic parameters in clinically healthy dogs. Vet J 174:62-68.
28. Wiinberg B, Jensen AL, Rojkjaer R, et al.: 2005, Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol 34:389-393.
29. Wiinberg B, Jensen AL, Rozanski E, et al.: 2009, Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs. Vet J 179:121-129.
30. Zambruni A, Thalheimer U, Leandro G, et al.: 2004, Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis 15:103-107.